Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-11

FDA Approved: CEVIMELINE HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approves cevimeline hydrochloride as an original ANDA submission from Zydus Lifesciences Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cevimeline hydrochloride (cevimeline hydrochloride)

Snippet

ORIG AP for CEVIMELINE HYDROCHLORIDE (CEVIMELINE HYDROCHLORIDE)